CY1017A - M-dioxane-5-methylamine analgesics - Google Patents

M-dioxane-5-methylamine analgesics

Info

Publication number
CY1017A
CY1017A CY1017A CY101773A CY1017A CY 1017 A CY1017 A CY 1017A CY 1017 A CY1017 A CY 1017A CY 101773 A CY101773 A CY 101773A CY 1017 A CY1017 A CY 1017A
Authority
CY
Cyprus
Prior art keywords
analgesics
methylamine
dioxane
methylamine analgesics
Prior art date
Application number
CY1017A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY1017A publication Critical patent/CY1017A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY1017A 1972-12-08 1973-12-10 M-dioxane-5-methylamine analgesics CY1017A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (1)

Publication Number Publication Date
CY1017A true CY1017A (en) 1979-11-23

Family

ID=23214841

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1017A CY1017A (en) 1972-12-08 1973-12-10 M-dioxane-5-methylamine analgesics

Country Status (27)

Country Link
JP (2) JPS5742633B2 (ru)
AR (3) AR206306A1 (ru)
AT (2) AT330773B (ru)
BE (1) BE808340A (ru)
BG (4) BG22386A3 (ru)
CA (2) CA1014560A (ru)
CH (4) CH605903A5 (ru)
CS (3) CS222209B2 (ru)
CY (1) CY1017A (ru)
DD (3) DD110864A5 (ru)
DE (1) DE2361340C2 (ru)
DK (1) DK134717B (ru)
ES (4) ES421290A1 (ru)
FR (1) FR2209578B1 (ru)
GB (2) GB1455998A (ru)
HK (1) HK60479A (ru)
HU (2) HU168763B (ru)
IE (1) IE40226B1 (ru)
IL (1) IL43773A (ru)
KE (1) KE2976A (ru)
MY (1) MY8000064A (ru)
NL (1) NL7316839A (ru)
PH (2) PH15197A (ru)
SE (3) SE403377B (ru)
SU (4) SU578001A3 (ru)
YU (3) YU36171B (ru)
ZA (1) ZA739207B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2847177B1 (en) * 2012-05-09 2017-10-11 Boehringer Ingelheim International GmbH Methods for making oxetan-3-ylmethanamines
LV14983B (lv) * 2013-10-15 2015-06-20 Olainfarm, A/S Fenibuta ražošanas starpproduktu iegūšanas paņēmiens

Also Published As

Publication number Publication date
ES444911A1 (es) 1977-09-01
YU35447B (en) 1981-02-28
ZA739207B (en) 1975-07-30
NL7316839A (ru) 1974-06-11
CA1014560A (en) 1977-07-26
DD109625A5 (ru) 1974-11-12
SE7701795L (sv) 1977-02-17
ES421291A1 (es) 1976-07-01
ES421290A1 (es) 1976-07-01
YU318473A (en) 1980-09-25
SE403377B (sv) 1978-08-14
IL43773A (en) 1979-05-31
HU168763B (ru) 1976-07-28
SE7701796L (sv) 1977-02-17
HU168620B (ru) 1976-06-28
CS222209B2 (en) 1983-05-27
IE40226L (en) 1974-06-08
AU6321773A (en) 1975-06-05
FR2209578B1 (ru) 1977-09-02
DE2361340C2 (de) 1983-11-24
JPS5734835B2 (ru) 1982-07-26
ES444716A1 (es) 1977-05-16
DK134717C (ru) 1977-05-31
DD115653A5 (ru) 1975-10-12
GB1455998A (en) 1976-11-17
CS222208B2 (en) 1983-05-27
CH619219A5 (en) 1980-09-15
AR212416A1 (es) 1978-07-14
YU318573A (en) 1981-06-30
DD110864A5 (ru) 1975-01-12
ATA1026173A (de) 1976-01-15
SU587861A3 (ru) 1978-01-05
CH605903A5 (ru) 1978-10-13
PH15197A (en) 1982-09-17
SU648081A3 (ru) 1979-02-15
BG26205A4 (bg) 1979-02-15
AR206306A1 (es) 1976-07-15
SU663305A3 (ru) 1979-05-15
HK60479A (en) 1979-08-31
ATA1026073A (de) 1975-10-15
BG21409A3 (bg) 1976-05-20
JPS4987680A (ru) 1974-08-22
IL43773A0 (en) 1974-03-14
CA1024150A (en) 1978-01-10
CH614439A5 (en) 1979-11-30
CS193480B2 (en) 1979-10-31
DK134717B (da) 1977-01-03
MY8000064A (en) 1980-12-31
YU36171B (en) 1982-02-25
BE808340A (fr) 1974-06-07
JPS4987681A (ru) 1974-08-22
DE2361340A1 (de) 1974-06-12
YU36020B (en) 1981-11-13
GB1455997A (en) 1976-11-17
SE428378B (sv) 1983-06-27
AT330773B (de) 1976-07-26
IE40226B1 (en) 1979-04-11
YU109380A (en) 1981-04-30
BG21223A3 (bg) 1976-03-20
SE417196B (sv) 1981-03-02
AT332396B (de) 1976-09-27
KE2976A (en) 1979-07-20
SU578001A3 (ru) 1977-10-25
BG22386A3 (bg) 1977-02-20
PH14923A (en) 1982-01-29
JPS5742633B2 (ru) 1982-09-09
FR2209578A1 (ru) 1974-07-05
AR212012A1 (es) 1978-04-28
CH630914A5 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
CS609973A2 (en) Nosic informace
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
GB1405253A (en) 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes
AU6329873A (en) Flameprofing
GB1407713A (en) 2-alkoxy-cephalosporins
AU6362373A (en) N-propargylacetanilide herbicedes
AU5993373A (en) N-sulphenylated carbamidoximes
GB1401579A (en) Indolo-quinolizines
GB1402226A (en) 3-cyanochromones
GB1408010A (en) Sulphamoylphenyl-imidazolidinones
GB1401735A (en) Imino-lactams
AU6332973A (en) Bulbholders
AU5711073A (en) Benzenesulfonyl-ureas benzenesulfonyl-ureas
AU5191873A (en) Benzylpyrimidines
GB1400667A (en) 4-spirocyclopropyl-androstenes
GB1405254A (en) Bis- substituted-henoxy- propanes
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
ZA732238B (en) Benzylamine analgesics
IL43773A0 (en) M-dioxane-5-methylamine analgesics
GB1415691A (en) Bracks
AU5900173A (en) Thiazolopyrimidines
GB1402045A (en) 11-o-methanesulphonylerythromycins
GB1404276A (en) 15-oxygenated-17a-unsubstituted-d-homosteroids
AU6379973A (en) Goniolens
GB1400604A (en) 2-acyl-5-nitrothiazoles